Bassetlaw: Hospital Trust chief is short-listed for major award

Mike Pinkerton, Chief Executive of Doncaster and Bassetlaw Hospitals, who has been shortlisted for the Health Service Journal Chief Executive of the Year Award
Mike Pinkerton, Chief Executive of Doncaster and Bassetlaw Hospitals, who has been shortlisted for the Health Service Journal Chief Executive of the Year Award
0
Have your say

The Chief Executive of Doncaster and Bassetlaw Hospitals has been shortlisted for one of the most prestigious awards in healthcare.

Mike Pinkerton, who was appointed chief executive at the Trust in 2012, is in the running for the Health Service Journal (HSJ) Chief Executive of the Year Award, which recognises excellent leadership in the face of recent pressures on the NHS.

“I am extremely humbled to have been shortlisted for such an award, which I regard as recognition of progress of the organisation towards delivering great healthcare and the contribution of every single member of staff,” said Mr Pinkerton.

“I am incredibly proud of everyone who is a part of Team DBH and of what we have achieved together.”

Under Mr Pinkerton’s leadership, the Trust has achieved some excellent results for the benefit of both patients and staff.

It has reduced the numbers of hospital acquired pressure ulcers, falls and serious incidents

It has also reduced waiting times for treatment and introduced seven day end of life services.

The Trust was also recently voted the best healthcare provider in the country to work for by its new members of staff.

“I would like to congratulate Mike on being short-listed for this award,” added

Chris Scholey, Trust chairman.

“Mike is refreshing to work with and his commitment, empathy and passion for the local community are evident in everything he does here at the Trust.”

Doncaster and Bassetlaw Hospitals is also poised for success in the Clinical Research Impact category, having been shortlisted for their Research and Development strategy.

Their new approach is credited for increasing in the number of studies at the Trust and for offering more patients the option of new drug treatments.

The awards will be presented on November 18 at the Grosvenor Hotel in London.